Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 757 to 767 of 767 entries
Sorted by: Best Match Show Resources per page
Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma.

Cellular and molecular bioengineering

Tang-Quan KR, Xi Y, Hochman-Mendez C, Xiang Q, Lee PF, Sampaio LC, Taylor DA.
PMID: 33281992
Cell Mol Bioeng. 2020 Jul 27;13(6):633-645. doi: 10.1007/s12195-020-00634-z. eCollection 2020 Dec.

INTRODUCTION: Recellularization of organ decellularized extracellular matrix (dECM) offers a potential solution for organ shortage in allograft transplantation. Cell retention rates have ranged from 10 to 54% in varying approaches for reseeding cells in whole organ dECM scaffolds. We...

Cite
Tang-Quan KR, Xi Y, Hochman-Mendez C, et al. Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma. Cell Mol Bioeng. 2020;13(6):633-645doi: 10.1007/s12195-020-00634-z.
Tang-Quan, K. R., Xi, Y., Hochman-Mendez, C., Xiang, Q., Lee, P. F., Sampaio, L. C., & Taylor, D. A. (2020). Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma. Cellular and molecular bioengineering, 13(6), 633-645. https://doi.org/10.1007/s12195-020-00634-z
Tang-Quan, Karis R, et al. "Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma." Cellular and molecular bioengineering vol. 13,6 (2020): 633-645. doi: https://doi.org/10.1007/s12195-020-00634-z
Tang-Quan KR, Xi Y, Hochman-Mendez C, Xiang Q, Lee PF, Sampaio LC, Taylor DA. Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma. Cell Mol Bioeng. 2020 Jul 27;13(6):633-645. doi: 10.1007/s12195-020-00634-z. eCollection 2020 Dec. PMID: 33281992; PMCID: PMC7704833.
Copy Download .nbib Format: NLM
CoV2-Detect-Net: Design of COVID-19 prediction model based on hybrid DE-PSO with SVM using chest X-ray images.

Information sciences

Dixit A, Mani A, Bansal R.
PMID: 33840820
Inf Sci (N Y). 2021 Sep;571:676-692. doi: 10.1016/j.ins.2021.03.062. Epub 2021 Apr 06.

For Covid-19 suspected cases, it is critical to diagnose them accurately and rapidly so that they can be isolated and provided with required medical care. A self-learning automation model will be helpful to diagnose the COVID-19 suspected individual using...

Cite
Dixit A, Mani A, Bansal R. CoV2-Detect-Net: Design of COVID-19 prediction model based on hybrid DE-PSO with SVM using chest X-ray images. Inf Sci (N Y). 2021;571:676-692doi: 10.1016/j.ins.2021.03.062.
Dixit, A., Mani, A., & Bansal, R. (2021). CoV2-Detect-Net: Design of COVID-19 prediction model based on hybrid DE-PSO with SVM using chest X-ray images. Information sciences, 571676-692. https://doi.org/10.1016/j.ins.2021.03.062
Dixit, Abhishek, et al. "CoV2-Detect-Net: Design of COVID-19 prediction model based on hybrid DE-PSO with SVM using chest X-ray images." Information sciences vol. 571 (2021): 676-692. doi: https://doi.org/10.1016/j.ins.2021.03.062
Dixit A, Mani A, Bansal R. CoV2-Detect-Net: Design of COVID-19 prediction model based on hybrid DE-PSO with SVM using chest X-ray images. Inf Sci (N Y). 2021 Sep;571:676-692. doi: 10.1016/j.ins.2021.03.062. Epub 2021 Apr 06. PMID: 33840820; PMCID: PMC8021529.
Copy Download .nbib Format: NLM
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.

Frontiers in microbiology

Raghav S, Ghosh A, Turuk J, Kumar S, Jha A, Madhulika S, Priyadarshini M, Biswas VK, Shyamli PS, Singh B, Singh N, Singh D, Datey A, Avula K, Smita S, Sabat J, Bhattacharya D, Kshatri JS, Vasudevan D, Suryawanshi A, Dash R, Senapati S, Beuria TK, Swain R, Chattopadhyay S, Syed GH, Dixit A, Prasad P, Pati S, Parida A.
PMID: 33329480
Front Microbiol. 2020 Nov 23;11:594928. doi: 10.3389/fmicb.2020.594928. eCollection 2020.

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has emerged as a global pandemic worldwide. In this study, we used ARTIC primers-based amplicon sequencing to profile 225 SARS-CoV-2 genomes from India. Phylogenetic...

Cite
Raghav S, Ghosh A, Turuk J, et al. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity. Front Microbiol. 2020;11:594928doi: 10.3389/fmicb.2020.594928.
Raghav, S., Ghosh, A., Turuk, J., Kumar, S., Jha, A., Madhulika, S., Priyadarshini, M., Biswas, V. K., Shyamli, P. S., Singh, B., Singh, N., Singh, D., Datey, A., Avula, K., Smita, S., Sabat, J., Bhattacharya, D., Kshatri, J. S., Vasudevan, D., Suryawanshi, A., Dash, R., Senapati, S., Beuria, T. K., Swain, R., Chattopadhyay, S., Syed, G. H., Dixit, A., Prasad, P., Pati, S., & Parida, A. (2020). Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity. Frontiers in microbiology, 11594928. https://doi.org/10.3389/fmicb.2020.594928
Raghav, Sunil, et al. "Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity." Frontiers in microbiology vol. 11 (2020): 594928. doi: https://doi.org/10.3389/fmicb.2020.594928
Raghav S, Ghosh A, Turuk J, Kumar S, Jha A, Madhulika S, Priyadarshini M, Biswas VK, Shyamli PS, Singh B, Singh N, Singh D, Datey A, Avula K, Smita S, Sabat J, Bhattacharya D, Kshatri JS, Vasudevan D, Suryawanshi A, Dash R, Senapati S, Beuria TK, Swain R, Chattopadhyay S, Syed GH, Dixit A, Prasad P, Pati S, Parida A. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity. Front Microbiol. 2020 Nov 23;11:594928. doi: 10.3389/fmicb.2020.594928. eCollection 2020. PMID: 33329480; PMCID: PMC7732478.
Copy Download .nbib Format: NLM
Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity.

Computational and structural biotechnology journal

Kumar S, Singh B, Kumari P, Kumar PV, Agnihotri G, Khan S, Kant Beuria T, Syed GH, Dixit A.
PMID: 33841751
Comput Struct Biotechnol J. 2021;19:1998-2017. doi: 10.1016/j.csbj.2021.04.014. Epub 2021 Apr 07.

The SARS-CoV2 is a highly contagious pathogen that causes COVID-19 disease. It has affected millions of people globally with an average lethality of ~3%. There is an urgent need of drugs for the treatment of COVID-19. In the current...

Cite
Kumar S, Singh B, Kumari P, et al. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Comput Struct Biotechnol J. 2021;19:1998-2017doi: 10.1016/j.csbj.2021.04.014.
Kumar, S., Singh, B., Kumari, P., Kumar, P. V., Agnihotri, G., Khan, S., Kant Beuria, T., Syed, G. H., & Dixit, A. (2021). Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Computational and structural biotechnology journal, 191998-2017. https://doi.org/10.1016/j.csbj.2021.04.014
Kumar, Sugandh, et al. "Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity." Computational and structural biotechnology journal vol. 19 (2021): 1998-2017. doi: https://doi.org/10.1016/j.csbj.2021.04.014
Kumar S, Singh B, Kumari P, Kumar PV, Agnihotri G, Khan S, Kant Beuria T, Syed GH, Dixit A. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Comput Struct Biotechnol J. 2021;19:1998-2017. doi: 10.1016/j.csbj.2021.04.014. Epub 2021 Apr 07. PMID: 33841751; PMCID: PMC8025584.
Copy Download .nbib Format: NLM
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.

Lancet (London, England)

Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ.
PMID: 34793741
Lancet. 2021 Dec 11;398(10317):2186-2192. doi: 10.1016/S0140-6736(21)02507-1. Epub 2021 Nov 15.

Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 vaccines have received emergency use authorisations from the US Food...

Cite
Omer SB, Benjamin RM, Brewer NT, et al. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. Lancet. 2021;398(10317):2186-2192doi: 10.1016/S0140-6736(21)02507-1.
Omer, S. B., Benjamin, R. M., Brewer, N. T., Buttenheim, A. M., Callaghan, T., Caplan, A., Carpiano, R. M., Clinton, C., DiResta, R., Elharake, J. A., Flowers, L. C., Galvani, A. P., Lakshmanan, R., Maldonado, Y. A., McFadden, S. M., Mello, M. M., Opel, D. J., Reiss, D. R., Salmon, D. A., Schwartz, J. L., Sharfstein, J. M., & Hotez, P. J. (2021). Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. Lancet (London, England), 398(10317), 2186-2192. https://doi.org/10.1016/S0140-6736(21)02507-1
Omer, Saad B, et al. "Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA." Lancet (London, England) vol. 398,10317 (2021): 2186-2192. doi: https://doi.org/10.1016/S0140-6736(21)02507-1
Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. Lancet. 2021 Dec 11;398(10317):2186-2192. doi: 10.1016/S0140-6736(21)02507-1. Epub 2021 Nov 15. PMID: 34793741; PMCID: PMC8592561.
Copy Download .nbib Format: NLM
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database.

Rheumatology (Oxford, England)

Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airò P, Distler J, Distler O, Rosato E.
PMID: 33769468
Rheumatology (Oxford). 2021 Mar 26; doi: 10.1093/rheumatology/keab302. Epub 2021 Mar 26.

OBJECTIVES: Study aim was to evaluate estimated glomerular filtration rate (eGFR), its association with clinical disease and its predictive ability with mortality in systemic sclerosis (SSc) patients from the European Scleroderma Trials and Research Group (EUSTAR) database.METHODS: SSc patients...

Cite
Gigante A, Hoffmann-Vold AM, Fegatelli DA, et al. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab302.
Gigante, A., Hoffmann-Vold, A. M., Fegatelli, D. A., Gabrielli, A., Leodori, G., Coleiro, B., De Santis, M., Dagna, L., Alegre-Sancho, J. J., Montecucco, C., Carreira, P. E., Balbir-Gurman, A., Doria, A., Riemekasten, G., Airò, P., Distler, J., Distler, O., Rosato, E. (2021). Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab302
Gigante, Antonietta, et al. "Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab302
Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airò P, Distler J, Distler O, Rosato E. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology (Oxford). 2021 Mar 26; doi: 10.1093/rheumatology/keab302. Epub 2021 Mar 26. PMID: 33769468.
Copy Download .nbib Format: NLM
Outcomes of dietary management approaches in active ulcerative colitis: A systematic review.

Clinical nutrition (Edinburgh, Scotland)

Marsh A, Rindfleish S, Bennett K, Croft A, Chachay V.
PMID: 34999323
Clin Nutr. 2021 Dec 10;41(2):298-306. doi: 10.1016/j.clnu.2021.12.007. Epub 2021 Dec 10.

BACKGROUND & AIMS: The dietary management of active ulcerative colitis (UC) is currently poorly understood. Due to the lack of clinical guidelines for this population, diet choice may be based on the personal judgement of the clinician, and without...

Cite
Marsh A, Rindfleish S, Bennett K, et al. Outcomes of dietary management approaches in active ulcerative colitis: A systematic review. Clin Nutr. 2021;41(2):298-306doi: 10.1016/j.clnu.2021.12.007.
Marsh, A., Rindfleish, S., Bennett, K., Croft, A., & Chachay, V. (2021). Outcomes of dietary management approaches in active ulcerative colitis: A systematic review. Clinical nutrition (Edinburgh, Scotland), 41(2), 298-306. https://doi.org/10.1016/j.clnu.2021.12.007
Marsh, Abigail, et al. "Outcomes of dietary management approaches in active ulcerative colitis: A systematic review." Clinical nutrition (Edinburgh, Scotland) vol. 41,2 (2021): 298-306. doi: https://doi.org/10.1016/j.clnu.2021.12.007
Marsh A, Rindfleish S, Bennett K, Croft A, Chachay V. Outcomes of dietary management approaches in active ulcerative colitis: A systematic review. Clin Nutr. 2021 Dec 10;41(2):298-306. doi: 10.1016/j.clnu.2021.12.007. Epub 2021 Dec 10. PMID: 34999323.
Copy Download .nbib Format: NLM
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.

Cancers

Bouroumeau A, Bussot L, Hamaidia S, Garcìa-Sandoval A, Bergan-Dahl A, Betton-Fraisse P, Duley S, Fournier C, Aucagne R, Adrait A, Couté Y, McLeer A, Col E, David-Boudet L, Raskovalova T, Jacob MC, Vettier C, Chevalier S, Carras S, Lefebvre C, Algrin C, Gressin R, Callanan MB, Sartelet H, Bonnefoix T, Emadali A.
PMID: 34885010
Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235900.

R-CHOP immuno-chemotherapy significantly improved clinical management of diffuse large B-cell lymphoma (DLBCL). However, 30-40% of DLBCL patients still present a refractory disease or relapse. Most of the prognostic markers identified to date fail to accurately stratify high-risk DLBCL patients....

Cite
Bouroumeau A, Bussot L, Hamaidia S, et al. CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235900.
Bouroumeau, A., Bussot, L., Hamaidia, S., Garcìa-Sandoval, A., Bergan-Dahl, A., Betton-Fraisse, P., Duley, S., Fournier, C., Aucagne, R., Adrait, A., Couté, Y., McLeer, A., Col, E., David-Boudet, L., Raskovalova, T., Jacob, M. C., Vettier, C., Chevalier, S., Carras, S., Lefebvre, C., Algrin, C., Gressin, R., Callanan, M. B., Sartelet, H., Bonnefoix, T., & Emadali, A. (2021). CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL. Cancers, 13(23), . https://doi.org/10.3390/cancers13235900
Bouroumeau, Antonin, et al. "CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235900
Bouroumeau A, Bussot L, Hamaidia S, Garcìa-Sandoval A, Bergan-Dahl A, Betton-Fraisse P, Duley S, Fournier C, Aucagne R, Adrait A, Couté Y, McLeer A, Col E, David-Boudet L, Raskovalova T, Jacob MC, Vettier C, Chevalier S, Carras S, Lefebvre C, Algrin C, Gressin R, Callanan MB, Sartelet H, Bonnefoix T, Emadali A. CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL. Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235900. PMID: 34885010; PMCID: PMC8656558.
Copy Download .nbib Format: NLM
Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells.

Toxicology in vitro : an international journal published in association with BIBRA

Singh D, Mohapatra P, Kumar S, Behera S, Dixit A, Sahoo SK.
PMID: 34883246
Toxicol In Vitro. 2021 Dec 06;79:105293. doi: 10.1016/j.tiv.2021.105293. Epub 2021 Dec 06.

Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis and remains highly aggressive despite current advancements in therapies. Chemoresistance and high metastatic nature of PDAC is attributed to a small subset of stem-like cells within the tumor known as...

Cite
Singh D, Mohapatra P, Kumar S, et al. Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells. Toxicol In Vitro. 2021;79:105293doi: 10.1016/j.tiv.2021.105293.
Singh, D., Mohapatra, P., Kumar, S., Behera, S., Dixit, A., & Sahoo, S. K. (2021). Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells. Toxicology in vitro : an international journal published in association with BIBRA, 79105293. https://doi.org/10.1016/j.tiv.2021.105293
Singh, Deepika, et al. "Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells." Toxicology in vitro : an international journal published in association with BIBRA vol. 79 (2021): 105293. doi: https://doi.org/10.1016/j.tiv.2021.105293
Singh D, Mohapatra P, Kumar S, Behera S, Dixit A, Sahoo SK. Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells. Toxicol In Vitro. 2021 Dec 06;79:105293. doi: 10.1016/j.tiv.2021.105293. Epub 2021 Dec 06. PMID: 34883246.
Copy Download .nbib Format: NLM
An Underexamined Inequality: Cultural and Psychological Barriers to Men’s Engagement With Communal Roles.

Croft A, Schmader T, Block K.
UIID-AD: 3613
2015;343-370. doi: 10.1177/1088868314564789.

Social psychological research has sought to understand and mitigate the psychological barriers that block women’s interest, performance, and advancement in male-dominated, agentic roles (e.g., science, technology, engineering, and math). Research has not, however, correspondingly examined men’s underrepresentation in communal...

Cite
Croft A, Schmader T, Block K. An Underexamined Inequality: Cultural and Psychological Barriers to Men’s Engagement With Communal Roles. 2015;343-370doi: 10.1177/1088868314564789.
Croft, A., Schmader, T., & Block, K. (2015). An Underexamined Inequality: Cultural and Psychological Barriers to Men’s Engagement With Communal Roles. 343-370. https://doi.org/10.1177/1088868314564789
Croft, A, et al. "An Underexamined Inequality: Cultural and Psychological Barriers to Men’s Engagement With Communal Roles." vol. (2015): 343-370. doi: https://doi.org/10.1177/1088868314564789
Croft A, Schmader T, Block K. An Underexamined Inequality: Cultural and Psychological Barriers to Men’s Engagement With Communal Roles. 2015;343-370. doi: 10.1177/1088868314564789. UIID-AD: 3613.
Copy Download .nbib Format: NLM
An Underexamined Inequality: Cultural and Psychological Barriers to Men's Engagement With Communal Roles.

Croft A, Schmader T, Block K.
UIID-AD: 3214
2015; doi: 10.1177/1088868314564789.

Social psychological research has sought to understand and mitigate the psychological barriers that block women's interest, performance, and advancement in male-dominated, agentic roles (e.g., science, technology, engineering, and math). Research has not, however, correspondingly examined men's underrepresentation in communal...

Cite
Croft A, Schmader T, Block K. An Underexamined Inequality: Cultural and Psychological Barriers to Men's Engagement With Communal Roles. 2015;doi: 10.1177/1088868314564789.
Croft, A., Schmader, T., & Block, K. (2015). An Underexamined Inequality: Cultural and Psychological Barriers to Men's Engagement With Communal Roles. . https://doi.org/10.1177/1088868314564789
Croft, A, et al. "An Underexamined Inequality: Cultural and Psychological Barriers to Men's Engagement With Communal Roles." vol. (2015). doi: https://doi.org/10.1177/1088868314564789
Croft A, Schmader T, Block K. An Underexamined Inequality: Cultural and Psychological Barriers to Men's Engagement With Communal Roles. 2015; doi: 10.1177/1088868314564789. UIID-AD: 3214.
Copy Download .nbib Format: NLM
Showing 757 to 767 of 767 entries